Moneycontrol
results
Jump to
2 Results Found
  • With 3 new expansions, FY12 to see 25% growth: Parabolic May 19, 2011 03:30 PM IST

    With 3 new expansions, FY12 to see 25% growth: Parabolic

    Parabolic Drugs recently announced its results for the fourth quarter and for the financial year that ended March 31, 2011. Vineet Gupta, director of the company, says he is hopeful that new expansions “will help contribute to further margin expansion.”

  • Parabolic Drugs eyes Rs 900cr sales next year Feb 02, 2011 02:35 PM IST

    Parabolic Drugs eyes Rs 900cr sales next year

    In an interview CNBC-TV18, Vineet Gupta, Director, Parabolic Drugs, speaks about the results and gives his outlook going forward.

Sections